53.7 F
Pakistan
Thursday, October 29, 2026
HomeHealthLilly's next-gen drug outperforms Ozempic in weight loss trial

Lilly’s next-gen drug outperforms Ozempic in weight loss trial

Lilly’s next-gen drug outperforms Ozempic in weight loss trialEli Lilly’s experimental next-generation drug retatrutide achieved a greater therapeutic response of Novo Nordisk’s Ozempic on blood sugar control and produced greater than double the reduction in body weight in a study of. ..

Read full story on The News International

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -
Google search engine

Most Popular

Recent Comments